Difference in difference estimation
| No of LD | No of LD | No of LD | No of LD | No of LD (after excluding Iran and India) | |
| Model 1 | Model 2 | Model 3 | Model 4 | Model 5 | |
| Donor reimbursement programme | 0.054*** (0.009) | 0.149*** (0.010) | 0.114*** (0.011) | 0.138*** (0.011) | 0.156*** (0.011) |
| No of deceased donors (thousand) | −0.302*** (0.004) | −0.342*** (0.006) | −0.196*** (0.007) | −0.214*** (0.007) | 0.029*** (0.008) |
| Health expenditure/GDP | −0.065*** (0.003) | −0.068*** (0.003) | −0.042*** (0.004) | −0.012*** (0.004) | |
| Out of pocket health expenditure | 0.007*** (0.001) | 0.008*** (0.001) | 0.005*** (0.001) | 0.000 (0.001) | |
| GDP per capita (thousand USD) | 0.007*** (0.002) | −0.002 (0.002) | −0.034*** (0.002) | ||
| GDP growth rate | 0.013*** (0.001) | 0.015*** (0.001) | 0.018*** (0.001) | ||
| Population size (in million) | −0.012*** (<0.001) | −0.012*** (<0.001) | −0.033*** (0.001) | ||
| Population growth rate | 0.007 (0.007) | 0.006 (0.007) | −0.006 (0.007) | ||
| Financial globalisation | 0.007*** (<0.001) | 0.002*** (0.000) | |||
| Social globalisation | 0.035*** (0.001) | 0.038*** (0.001) | |||
| Political globalisation | −0.022*** (0.001) | −0.002* (0.001) | |||
| Country FE | Yes | Yes | Yes | Yes | Yes |
| Year FE | Yes | Yes | Yes | Yes | Yes |
| Number of observations | 1346 | 1224 | 1214 | 1198 | 1178 |
| Number of countries | 109 | 106 | 105 | 104 | 102 |
***p<0.01, **p<0.05, *p<0.1. The outcome variable is total number of living kidney donations. SEs are in parenthesis. The reported coefficient is the log of expected count for all independent variables. The incidence rate ratio for reimbursement programme is 1.06 in model 1, 1.16 in model 2, 1.12 in model 3, 1.15 in model 4 and 1.17 in model 5. Model 5 excludes data of Iran and India.
FE, fixed effects.